More tools:Markets·Screener·Research·Chat

Concord Medical Services Holding Limited (CCM) Financial Statements

Concord Medical Services Holding Limited
SIC 6719 · LIFE INSURANCE
FIGI BBG001T62CP6
XNYS · usd
4.35▼ 0.33 (-7.05%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close4.68
Day's Range3.97 – 4.67
52-Week Range3.13 – 6.98
Volume12.9K
Avg Volume88.0K
Share Statistics
Shares Outstanding
Employees595
ExchangeXNYS
Listed2009-12-11
Share count as of December 31, 2025
Loading Income Statement…
Key questions about Concord Medical Services Holding Limited (CCM)
What is Concord Medical Services Holding Limited's Market Cap?
Concord Medical Services Holding Limited's Market Cap is $566.6M, based on as-reported figures from SEC (XBRL) filings.
What is Concord Medical Services Holding Limited's Enterprise Value?
Concord Medical Services Holding Limited's Enterprise Value is $1.0B, based on as-reported figures from SEC (XBRL) filings.
What is Concord Medical Services Holding Limited's Price / Sales?
Concord Medical Services Holding Limited's Price / Sales is 8.7×, based on as-reported figures from SEC (XBRL) filings.
What is Concord Medical Services Holding Limited's EV / Revenue?
Concord Medical Services Holding Limited's EV / Revenue is 15.7×, based on as-reported figures from SEC (XBRL) filings.
What is Concord Medical Services Holding Limited's EV / EBITDA?
Concord Medical Services Holding Limited's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Concord Medical Services Holding Limited's Revenue (TTM)?
Concord Medical Services Holding Limited's Revenue (TTM) is $65.0M, based on as-reported figures from SEC (XBRL) filings.
What is Concord Medical Services Holding Limited's Net Income (TTM)?
Concord Medical Services Holding Limited's Net Income (TTM) is -$13.3M, based on as-reported figures from SEC (XBRL) filings.
What is Concord Medical Services Holding Limited's EBITDA?
Concord Medical Services Holding Limited's EBITDA is -$17.4M, based on as-reported figures from SEC (XBRL) filings.
What is Concord Medical Services Holding Limited's Diluted EPS (TTM)?
Concord Medical Services Holding Limited's Diluted EPS (TTM) is -0.10, based on as-reported figures from SEC (XBRL) filings.
What is Concord Medical Services Holding Limited's EBITDA Margin?
Concord Medical Services Holding Limited's EBITDA Margin is -26.8%, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
Revenues, net of value-added tax
YoY growth+19.9%
Cost of revenues
Gross loss
% of revenue5.6%
Operating expenses:
Selling expenses
General and administrative expenses
Impairment of long-term investments
Operating loss
% of revenue-56.8%
Interest expense (including interest expense to related party amounting to RMB14,308, RMB18,988 and RMB8,445 (US$1,208) for the years ended December 31, 2023, 2024 and 2025, respectively)
Foreign exchange (loss) gain, net
Interest income (including interest income from related party amounting to RMB6,813, RMB7,359 and RMB7,158 (US$1,024) for the years ended December 31, 2023, 2024 and 2025, respectively)
Change in fair value of derivative liability—
Income from equity method investments
Loss on disposal of a subsidiary—
Other expenses, net
Gain/ (loss) on sale of partial interests in an equity method investment
Changes in fair value of short-term investments—
Loss before income tax
Income tax benefit/(expense)
Net loss
% of revenue-82.4%
Net loss attributable to noncontrolling interests
Net loss attributable to Concord Medical Services Holdings Limited
% of revenue-20.2%
Basic
Diluted